Julien Delrieu

Summary

Country: France

Publications

  1. doi request reprint Amyloid beta peptide immunotherapy in Alzheimer disease
    J Delrieu
    Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, 170, avenue de Casselardit, 31059 Toulouse Cedex 9, France Electronic address
    Rev Neurol (Paris) 170:739-48. 2014
  2. doi request reprint Gantenerumab for the treatment of Alzheimer's disease
    Julien Delrieu
    Toulouse University Hospital, Alzheimer s Disease Clinical Research Centre, 170 avenue de Casselardit, Gerontopole, 31059 Toulouse Cedex, INSERM UMR 1027, France
    Expert Opin Biol Ther 12:1077-86. 2012
  3. doi request reprint 'Clinical trials in Alzheimer's disease': immunotherapy approaches
    Julien Delrieu
    Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, France INSERM 1027, France
    J Neurochem 120:186-93. 2012
  4. doi request reprint Sensory alien hand syndrome in corticobasal degeneration: a cerebral blood flow study
    Julien Delrieu
    Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, Toulouse, France
    Mov Disord 25:1288-91. 2010
  5. doi request reprint [The Alzheimer's disease: how to estimate the impact of the pathology and the treatment?]
    Julien Delrieu
    Centre de Recherche Clinique sur la Maladie d Alzheimer, Gerontopole, Hôpital Universitaire de Toulouse, Toulouse, France INSERM U558, Toulouse, France
    Therapie 65:423-8. 2010
  6. doi request reprint Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy
    Julien Delrieu
    Alzheimers Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, Toulouse, France
    CNS Drugs 25:213-26. 2011
  7. doi request reprint Physical Activity and Cognitive Function in Middle-Aged and Older Adults: An Analysis of 104,909 People From 20 Countries
    Philipe de Souto Barreto
    Gérontopôle of Toulouse, University Hospital of Toulouse CHU Toulouse, Toulouse, France UMR INSERM 1027, University of Toulouse III, Toulouse, France Electronic address
    Mayo Clin Proc 91:1515-1524. 2016
  8. doi request reprint Implementing Assessment of Cognitive Function and Frailty Into Primary Care: Data From Frailty and Alzheimer disease prevention into Primary care (FAP) Study Pilot
    Bertrand Fougère
    Gerontopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France Inserm UMR1027, Université de Toulouse III Paul Sabatier, Toulouse, France Electronic address
    J Am Med Dir Assoc . 2016
  9. doi request reprint Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study
    Julien Delrieu
    Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, Toulouse, France
    Int J Geriatr Psychiatry 30:470-7. 2015

Detail Information

Publications9

  1. doi request reprint Amyloid beta peptide immunotherapy in Alzheimer disease
    J Delrieu
    Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, 170, avenue de Casselardit, 31059 Toulouse Cedex 9, France Electronic address
    Rev Neurol (Paris) 170:739-48. 2014
    ....
  2. doi request reprint Gantenerumab for the treatment of Alzheimer's disease
    Julien Delrieu
    Toulouse University Hospital, Alzheimer s Disease Clinical Research Centre, 170 avenue de Casselardit, Gerontopole, 31059 Toulouse Cedex, INSERM UMR 1027, France
    Expert Opin Biol Ther 12:1077-86. 2012
    ..Immunotherapy directed against the β-amyloid peptide may be capable of slowing the rate of disease progression. Gantenerumab is the first fully human anti-β-amyloid monoclonal antibody...
  3. doi request reprint 'Clinical trials in Alzheimer's disease': immunotherapy approaches
    Julien Delrieu
    Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, France INSERM 1027, France
    J Neurochem 120:186-93. 2012
    ..Currently, several Aβ peptide immunotherapy approaches are under investigation but also against tau pathology...
  4. doi request reprint Sensory alien hand syndrome in corticobasal degeneration: a cerebral blood flow study
    Julien Delrieu
    Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, Toulouse, France
    Mov Disord 25:1288-91. 2010
    ..We observed significant decrease of regional cerebral blood flow over the nondominant thalamus in sAHS+ compared to sAHS- patients. This result suggests the involvement of the nondominant thalamus in sAHS...
  5. doi request reprint [The Alzheimer's disease: how to estimate the impact of the pathology and the treatment?]
    Julien Delrieu
    Centre de Recherche Clinique sur la Maladie d Alzheimer, Gerontopole, Hôpital Universitaire de Toulouse, Toulouse, France INSERM U558, Toulouse, France
    Therapie 65:423-8. 2010
    ..However, at present no biomarker is validated as surrogate endpoint. It seems today indispensable to use them in the therapeutic tries so as to validate and standardize their methods of acquisition, measure and analysis...
  6. doi request reprint Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy
    Julien Delrieu
    Alzheimers Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, Toulouse, France
    CNS Drugs 25:213-26. 2011
    ..There is currently insufficient evidence for recommending combination therapy in Alzheimer's disease...
  7. doi request reprint Physical Activity and Cognitive Function in Middle-Aged and Older Adults: An Analysis of 104,909 People From 20 Countries
    Philipe de Souto Barreto
    Gérontopôle of Toulouse, University Hospital of Toulouse CHU Toulouse, Toulouse, France UMR INSERM 1027, University of Toulouse III, Toulouse, France Electronic address
    Mayo Clin Proc 91:1515-1524. 2016
    ..To examine the associations of physical activity (PA) frequency (both moderate and vigorous intensity) and PA levels with cognitive function...
  8. doi request reprint Implementing Assessment of Cognitive Function and Frailty Into Primary Care: Data From Frailty and Alzheimer disease prevention into Primary care (FAP) Study Pilot
    Bertrand Fougère
    Gerontopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France Inserm UMR1027, Université de Toulouse III Paul Sabatier, Toulouse, France Electronic address
    J Am Med Dir Assoc . 2016
    ..In this article, we describe the organization, details of the evaluation, and provide the main characteristics of the first 200 patients assessed over a 6-month period...
  9. doi request reprint Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study
    Julien Delrieu
    Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, Toulouse, France
    Int J Geriatr Psychiatry 30:470-7. 2015
    ..The goal of this study is to evaluate brain metabolism in mild cognitive impairment (MCI) patients with and without apathy (as determined by the Neuropsychiatric Inventory Questionnaire)...